No. CosIng lists acetyl octapeptide-3, which is SNAP-8 as sellers describe it, as the reaction product of acetic acid and octapeptide-3 per the CosIng entry, not a botulinum toxin. A 2025 review calls acetyl hexapeptide-8 (Argireline), a different peptide, "botox-like"; in lab tests it inhibited neurotransmitter release with much lower efficacy than botulinum toxin A. We found no study measuring muscle activity after topical SNAP-8, and the one human study we found tested a multi-ingredient patch.

Peptides · Evidence-graded entry

SNAP-8 (acetyl octapeptide-3, as sellers describe it): what the evidence shows

Name: SNAP-8 (acetyl octapeptide-3, as sellers describe it): what the evidence shows
Creator: SoftMaxx AI Editorial
Published: 2026-09-30

SNAP-8, evidence-graded: the best support is one small human study of a multi-ingredient patch. Citations checked against PubMed and regulator records.

Written by SoftMaxx AI editorial · Citations checked against PubMed records · Updated 2026-10-01 · Not medically reviewed · How we grade evidence

SoftMaxx AI sells no peptides and takes no vendor money.

The verdict · strongest evidence Human, small or uncontrolled

Human, small or uncontrolled We found no trial of SNAP-8, which is acetyl octapeptide-3 as sellers describe it, on its own. The one human study we found tested an eye patch with acetyl octapeptide-3, a vitamin C derivative and cyclic lysophosphatidic acid, against a hyaluronic-acid placebo patch, in 24 people over 28 days.^[1]

What SNAP-8 is

As sellers describe it, SNAP-8 is acetyl octapeptide-3; we found no regulator record or study that names SNAP-8. The EU cosmetic-ingredient database (CosIng) lists acetyl octapeptide-3 as 'the reaction product of acetic acid and Octapeptide-3', with the functions humectant and skin conditioning per the CosIng entry. We found no study of injected SNAP-8.

In vitro (cells) (argireline data) These data are for argireline, a different peptide. Argireline is patterned on the N-terminal end of SNAP-25 ^[2] and, in its developers' lab tests, interfered with the SNARE complex and inhibited neurotransmitter release with much lower efficacy than botulinum toxin A ^[3]. In human cadaver skin, most of the applied argireline washed off the surface, what penetrated stayed mostly in the stratum corneum, and none was detected in the dermis ^[4], and a 2025 review calls its ability to reach nerve–muscle junctions uncertain ^[5]. We found no study of how far SNAP-8 itself gets into skin.^[2][3][4][5]

Claims vs. evidence

Each popular claim, graded by the strongest study behind it. The words in quotation marks are how the claim is marketed; the text after the grade is what the studies show.

Claim as marketedReduces expression lines (topical)Human, small or uncontrolled Microneedle patch with acetyl octapeptide-3 plus a vitamin C derivative and cyclic lysophosphatidic acid, against a hyaluronic-acid-only placebo patch, one eye each, applied overnight and assessed over 28 days (n=24); the peptide's contribution was not isolated.^[1]
Claim as marketedBotox-like muscle relaxationIn vitro (cells) (argireline data) The nearest data are argireline lab work, where argireline inhibited neurotransmitter release with much lower efficacy than botulinum toxin A. We found no study measuring muscle activity after topical SNAP-8.^[3]
Claim as marketedInjectable SNAP-8 for wrinklesNo supporting study We found no published human or animal study of injected SNAP-8. A 2026 review warns that unregulated injectable peptides carry risks of product contamination, manufacturing impurities and inaccurate dosing.^[6]

Common myths, checked

Common beliefSNAP-8 is a topical Botox.In vitro (cells) (argireline data) The nearest data are argireline lab work, where argireline inhibited nerve-signal release with much lower efficacy than botulinum toxin A. In lab tests on human skin, most of the applied argireline washed off the surface and what penetrated stayed mostly in the skin's outer layer; we found no study showing SNAP-8 reaches or relaxes facial muscles.^[3][4][5]
Common beliefInjecting SNAP-8 is a safe, stronger way to use it.Expert review We found no published human or animal study of injected SNAP-8. A 2026 review warns that unregulated injectable peptides carry risks of product contamination, manufacturing impurities and inaccurate dosing.^[6]

Doses used in studies (not a recommendation)

These are the amounts given to the people, animals or cells in the cited studies, copied as reported. They are a record of what was tested, not dosing instructions, and nothing here says what you should take.

Studied in	Route	Amount reported	How often	How long	n	Source
Humans	topical via dissolving microneedle patch (periorbital)	acetyl octapeptide-3 content not stated in abstract (multi-ingredient patch)	overnight (number of applications not stated in abstract)	28 days	24	^[1] 24 healthy subjects; active patch on one eye, placebo patch on the other

Side effects and risks

Human, small or uncontrolled No adverse effects reported in the 24-person, 28-day microneedle-patch study^[1]
Expert review Injected gray-market peptides: contamination, impurity and dosing risks (review); we found no safety study of injected SNAP-8^[6]

Regulatory status (checked 2026-09-30)

United States (FDA)We found no FDA-approved product containing SNAP-8 in Drugs@FDA (searched 2026-10-01). (FDA: Drugs@FDA search: snap-8 — no approved product found) FDA does not approve cosmetic products or ingredients (other than color additives) before they go on the market, and a product intended to affect the structure or any function of the body is legally a drug. (FDA: Is It a Cosmetic, a Drug, or Both?)
CanadaWe found no product containing SNAP-8 in Health Canada’s Drug Product Database (searched 2026-10-01). (Health Canada: Health Canada Drug Product Database search: snap-8 — no product found)
Sport (WADA)WADA’s Prohibited List does not name SNAP-8. WADA states that topical cosmetic products may contain prohibited peptides or growth factors and that using cosmetic products containing such substances is prohibited; we found no WADA statement on whether SNAP-8 is one of them. (WADA: World Anti-Doping Code International Standard Prohibited List 2026; WADA: World Anti-Doping Agency Prohibited List)

Official sources: FDA: Is It a Cosmetic, a Drug, or Both? · WADA: World Anti-Doping Code International Standard Prohibited List 2026 · WADA: World Anti-Doping Agency Prohibited List

Report a side effect

If something went wrong after using any product, tell a clinician and report it. Reports are how regulators find contaminated or mislabeled products.

FDA MedWatch (United States)
Canada Vigilance Program (Canada)

Common questions

Is SNAP-8 Botox?

In vitro (cells) No. CosIng lists acetyl octapeptide-3, which is SNAP-8 as sellers describe it, as the reaction product of acetic acid and octapeptide-3 per the CosIng entry, not a botulinum toxin. A 2025 review calls acetyl hexapeptide-8 (Argireline), a different peptide, "botox-like" ^[5]; in lab tests it inhibited neurotransmitter release with much lower efficacy than botulinum toxin A ^[3]. We found no study measuring muscle activity after topical SNAP-8, and the one human study we found tested a multi-ingredient patch.^[3][1]

SNAP-8 peptide injection side effects?

Expert review A 2026 review warns that unregulated injectable peptides carry risks of product contamination, manufacturing impurities and inaccurate dosing. We found no human safety study of injected SNAP-8.^[6]

References

Every reference below was matched to its PubMed or DOI record (title checked) before publication. "Verified" means the paper exists and is the one named; what it supports is stated next to each claim.

Clinical Safety and Efficacy Evaluation of a Dissolving Microneedle Patch Having Dual Anti-Wrinkle Effects With Safe and Long-Term Activities. Ann Dermatol (2024). PubMed 39082657 DOI
The anti-wrinkle efficacy of argireline, a synthetic hexapeptide, in Chinese subjects: a randomized, placebo-controlled study. Am J Clin Dermatol (2013). PubMed 23417317 DOI
A synthetic hexapeptide (Argireline) with antiwrinkle activity. Int J Cosmet Sci (2002). PubMed 18498523 DOI
In vitro skin penetration of acetyl hexapeptide-8 from a cosmetic formulation. Cutan Ocul Toxicol (2015). PubMed 24754410 DOI
Acetyl Hexapeptide-8 in Cosmeceuticals-A Review of Skin Permeability and Efficacy. Int J Mol Sci (2025). PubMed 40565185 DOI
Dangers of Injectable Peptides and Other Unregulated "Biohacking" Drugs. Mo Med (2026). PubMed 42757290

Written by SoftMaxx AI editorial · Citations checked against PubMed records · Updated 2026-10-01 · Not medically reviewed. Editorial standards · Evidence grading and update log.